Dr Louise Sigfrid
ERGO Clinical Research Fellow
Louise Sigfrid is a Clinical Research Fellow and Public Health Specialist, with a main focus to strengthen preparedness to (re-) emerging infectious diseases through clinical research and capacity building.
Louise main focus is the PREPARE (Platform for European Preparedness Against (Re-) emerging Epidemics) project, studying incidence risk factors and clinical impact of infections with epidemic potential in Europe with a focus on acute respiratory infections, central nervous system infections, arbovirus and haemorrhagic fever syndromes in hospitalized and primary care patients.
Additionally, Louise supports the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) developing harmonised clinical research tools for characterization of emerging infections globally, including COVID-19.
Louise is lead for the Masters module in Health Protection at Brighton & Sussex Medical School and Honorary Academic Public Health Consultant at PHE.
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol
Sigfrid L. et al, (2021), Lancet Reg Health
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol.
Sigfrid L. et al, (2021), The Lancet regional health. Europe
Incidence and risk factors for persistent symptoms in adults previously hospitalised for COVID-19.
Munblit D. et al, (2021), Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
From severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) to coronavirus disease 2019 (COVID-19): a systematic review of the quality and responsiveness of clinical management guidelines in outbreak settings
Lipworth S. et al, (2021), Wellcome Open Research, 6, 170 - 170
Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe-results from the PED-MERMAIDS multicentre case-control study.
Kohns Vasconcelos M. et al, (2021), BMJ open respiratory research, 8